Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion type Assertion NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_head.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion description "[GCMB mRNA expression was lower in normal (0.4 +/- 0.1, mean +/- standard error of mean) parathyroid glands as compared to adenoma (3.5 +/- 1.7), hyperplasia (3.2 +/- 1.3 primary hyperparathyroidism [n = 11] and 7.6 +/- 4.8 secondary hyperparathyroidism [n = 5]), and cancer (3.6 +/- 1.3) ( P = .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion evidence source_evidence_literature NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion SIO_000772 15657585 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion wasDerivedFrom befree-20140225 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.
- NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_assertion wasGeneratedBy ECO_0000203 NP221113.RAxW-cGsq5lrAIePF8ZnQLy-OVxWQJeMtuDlRkdEYXG3s130_provenance.